12:00 AM
 | 
Aug 13, 2012
 |  BC Week In Review  |  Company News  |  Deals

Dicerna, Kyowa Hakko Kirin deal

Dicerna received an undisclosed milestone payment from Kyowa under an amended 2010 deal to develop and commercialize therapeutics utilizing Dicerna's Dicer Substrate short interfering RNA (DsiRNA)...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >